AngioDynamics. has filed a patent for a system to test ablation systems, including an optical box and catheter connector. The system includes qualitative and quantitative beam assessment devices, along with a processor to analyze beam profile and energy. The patent claim details a qualitative beam assessment device with a camera aligned with the optical box’s focal plane. GlobalData’s report on AngioDynamics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on AngioDynamics, Target mapping ablation catheters was a key innovation area identified from patents. AngioDynamics's grant share as of January 2024 was 52%. Grant share is based on the ratio of number of grants to total number of patents.
Beam assessment device for ablation system with optical box
See Also:
The patent application (Publication Number: US20230408329A1) describes a novel qualitative and quantitative beam assessment device designed to interface with an ablation system. The qualitative beam assessment device includes a camera housed within a catheter connector to record an image of the beam emitted by the optical box, with an attenuator to adjust the beam intensity. Additionally, an RFID chip is integrated to regulate the energy density of the beam. On the other hand, the quantitative beam assessment device measures the energy of the beam using an energy sensor and a guiding component to direct the beam accurately. Both devices are equipped with communication components to transmit data to a processor for analysis.
Furthermore, the patent application outlines a comprehensive system for testing an ablation system, incorporating both qualitative and quantitative beam assessment devices. The system includes a processor that receives data from both devices to determine the qualitative and quantitative conditions of the beam. The system also features a display device to showcase the results. The qualitative condition includes identifying failure modes such as misalignment of the beam, while the quantitative condition assesses factors like energy distribution and overall energy levels. The system aims to provide a thorough evaluation of the ablation system's performance, ensuring optimal functionality and safety during medical procedures.
To know more about GlobalData’s detailed insights on AngioDynamics, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
